Alkermes Plc at Cantor Fitzgerald Global Healthcare Conference Transcript
It's been around for a while, and I've admired for a long time. However, I only recently had an opportunity to pick up coverage of Alkermes, and I'm excited to do so. Frankly, I think that this is long been a neuro innovator that has been overlooked and it is becoming increasingly a more -- a company more focused on neuro innovation and developing a pipeline drugs -- pipeline of drugs meant to treat a range of neurological and psychiatric disorders. And in addition, it has a strong commercial base. So with me today is Blair Jackson, the company's Chief Operating Officer. Blair, welcome. Good to see you.
Nice to see you as well.
Questions & Answers
Thanks for joining. I think Blair we'll start probably with an overview and -- I like your socks, I'm a cyclist as well. And then we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
